Development of AR-V7 as a putative treatment selection marker for metastatic castration-resistant prostate cancer

Prostate cancer cells demonstrate a remarkable “addiction” to androgen receptor (AR) signaling in all stages of disease progression. As such, suppression of AR signaling remains the therapeutic goal in systemic treatment of prostate cancer. A number of molecular alterations arise in patients treated...

Descripción completa

Detalles Bibliográficos
Autor principal: Luo, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955182/
https://www.ncbi.nlm.nih.gov/pubmed/27174161
http://dx.doi.org/10.4103/1008-682X.178490